Veal GJ - Search Results

1

Excessive vincristine exposure in a child being treated for acute lymphoblastic leukaemia with underlying Dubin-Johnson syndrome: a case report.

Barnett S, Nyein AC, Galler M, Jamieson D, Davies M, Connor P, Veal GJ. Barnett S, et al. Among authors: veal gj. Cancer Chemother Pharmacol. 2023 Oct;92(4):325-328. doi: 10.1007/s00280-023-04565-0. Epub 2023 Jul 15. Cancer Chemother Pharmacol. 2023. PMID: 37452859 Free PMC article.

2

Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.

Fischer-Huchzermeyer S, Chikobava L, Stahn V, Zangarini M, Berry P, Veal GJ, Senner V, Mautner VF, Harder A. Fischer-Huchzermeyer S, et al. Among authors: veal gj. BMC Res Notes. 2018 Jul 28;11(1):520. doi: 10.1186/s13104-018-3630-0. BMC Res Notes. 2018. PMID: 30055648 Free PMC article.

3

Pharmacodynamic Therapeutic Drug Monitoring for Cancer: Challenges, Advances, and Future Opportunities.

Veal GJ, Amankwatia EB, Paludetto MN, Möcklinghoff T, Thomson F, André N, Ciccolini J, Chatelut E. Veal GJ, et al. Ther Drug Monit. 2019 Apr;41(2):142-159. doi: 10.1097/FTD.0000000000000606. Ther Drug Monit. 2019. PMID: 30883508 Free article. Review.

4

Malnourished Malawian patients presenting with large Wilms tumours have a decreased vincristine clearance rate.

Israels T, Damen CW, Cole M, van Geloven N, Boddy AV, Caron HN, Beijnen JH, Molyneux EM, Veal GJ. Israels T, et al. Among authors: veal gj. Eur J Cancer. 2010 Jul;46(10):1841-7. doi: 10.1016/j.ejca.2010.03.002. Epub 2010 Apr 9. Eur J Cancer. 2010. PMID: 20382523

5

Synthesis and biological evaluation of 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26).

Gomaa MS, Bridgens CE, Veal GJ, Redfern CP, Brancale A, Armstrong JL, Simons C. Gomaa MS, et al. Among authors: veal gj. J Med Chem. 2011 Oct 13;54(19):6803-11. doi: 10.1021/jm200695m. Epub 2011 Sep 8. J Med Chem. 2011. PMID: 21838328

6

In vitro screening of nucleoside analog combinations for potential use in anti-HIV therapy.

Veal GJ, Barry MG, Khoo SH, Back DJ. Veal GJ, et al. AIDS Res Hum Retroviruses. 1997 Apr 10;13(6):481-4. doi: 10.1089/aid.1997.13.481. AIDS Res Hum Retroviruses. 1997. PMID: 9100989

7

Modulation of signaling enhances the efficacy of the combination of satraplatin and erlotinib.

Avan A, Adema AD, Hoebe EK, Huijts CM, Avan A, Veal GJ, Ruijtenbeek R, Wosikowski K, Peters GJ. Avan A, et al. Among authors: veal gj. Curr Drug Targets. 2014;15(14):1312-21. doi: 10.2174/1389450115666141107110321. Curr Drug Targets. 2014. PMID: 25382189

8

Synergistic inhibition of HIV-1 by an antisense oligonucleotide and nucleoside analog reverse transcriptase inhibitors.

Veal GJ, Agrawal S, Byrn RA. Veal GJ, et al. Antiviral Res. 1998 Apr;38(1):63-73. doi: 10.1016/s0166-3542(98)00004-7. Antiviral Res. 1998. PMID: 9614005

9

Enhanced antitumor activity of P450 prodrug-based gene therapy using the low Km cyclophosphamide 4-hydroxylase P450 2B11.

Jounaidi Y, Chen CS, Veal GJ, Waxman DJ. Jounaidi Y, et al. Among authors: veal gj. Mol Cancer Ther. 2006 Mar;5(3):541-55. doi: 10.1158/1535-7163.MCT-05-0321. Mol Cancer Ther. 2006. PMID: 16546968

10

Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: potent CYP26 inhibitors and enhancers of all-trans retinoic acid activity in neuroblastoma cells.

Gomaa MS, Armstrong JL, Bobillon B, Veal GJ, Brancale A, Redfern CP, Simons C. Gomaa MS, et al. Among authors: veal gj. Bioorg Med Chem. 2008 Sep 1;16(17):8301-13. doi: 10.1016/j.bmc.2007.06.048. Epub 2007 Jun 29. Bioorg Med Chem. 2008. PMID: 18722776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters